Orion Biotechnology is a Swiss/Canadian clinical stage biotechnology company focused on immuno-oncology and novel discovery platform, which facilitates rapid, low cost development of chemokine analogs – a promising new class of drugs with broad therapeutic applications.

Products, services, technology

 

 

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2018
  • Number of employees in Switzerland
    1-9
Key business